All Pharma News
CMS Awards Tempus ADLT Status For xT CDx Test

CMS Awards Tempus ADLT Status For xT CDx Test
BUSINESSWIRE
02 Jul 2024
Share Share
SoftBank Group launches AI healthcare joint venture with Tempus AI

SoftBank Group launches AI healthcare joint venture with Tempus AI
REUTERS
27 Jun 2024
Share Share
Tempus Introduces New HER2 & FOLR1 Testing For Personalized Care

Tempus Introduces New HER2 & FOLR1 Testing For Personalized Care
BUSINESSWIRE
02 Jun 2024
Share Share
Tempus Releases New Data at AACR

Tempus Releases New Data at AACR
BUSINESSWIRE
08 Apr 2024
Share Share
Tempus Announces Abstracts Accepted For Presentation at the AACR

Tempus Announces Abstracts Accepted For Presentation at the AACR
BUSINESSWIRE
05 Apr 2024
Share Share
Tempus Announces the GEMINI Non-Small Cell Lung Cancer Study

Tempus Announces the GEMINI Non-Small Cell Lung Cancer Study
BUSINESSWIRE
12 Jul 2023
Share Share
Tempus Announces Companion Diagnostic Collaboration with TScan Therapeutics

Tempus Announces Companion Diagnostic Collaboration with TScan Therapeutics
BUSINESSWIRE
06 Jul 2023
Share Share
Tempus Announces Dr. Ned Sharpless as a Senior Strategic Advisor

Tempus Announces Dr. Ned Sharpless as a Senior Strategic Advisor
BUSINESSWIRE
10 May 2023
Share Share
Tempus clocks FDA approval for 648-gene cancer test

Tempus clocks FDA approval for 648-gene cancer test
Conor Hale FIERCE BIOTECH
08 May 2023
Share Share
Tempus founders build a drug discovery startup, Pathos AI, with $40M in sight

Tempus founders build a drug discovery startup, Pathos AI, with $40M in sight
Kyle LaHucik ENDPTS
03 Mar 2023
Share Share